Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia Study-2

NCT04598750 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT04598750
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04598750 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia Study-2
Lead sponsor
Karolinska Institutet
Phase
Observational
Overall status
Recruiting
Start date
June 15, 2021
Completion date
December 31, 2025
Enrollment
250 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

bleeding, neonatal thrombocytopenia